Brief: Medincell Has Secured An Additional EUR 13.8 Million In Non-Dilutive Financing From Leading European Commercial Banks And Bpifrance
13/10/2026 17:13
BRIEF-Medincell Has Secured An Additional EUR 13.8 Million In Non-Dilutive Financing From Leading European Commercial Banks And Bpifrance Oct 13 (Reuters) - Medincell SA MEDCL.PA:
MEDINCELL SA - HAS SECURED AN ADDITIONAL EUR 13.8 MILLION IN NON-DILUTIVE FINANCING FROM LEADING EUROPEAN COMMERCIAL BANKS AND BPIFRANCE
SECURES ADDITIONAL €13.80 MILLION LOAN, TOTAL NON-DILUTIVE FINANCING SINCE JULY 2026 €41.80 MILLION
REPAID 50% OF EIB LOAN AND EXTENDED DEBT MATURITY PROFILE THROUGH SEPT 2031
REPORTS €84.80 MILLION CASH AND CASH EQUIVALENTS AS OF MARCH 31, 2026
Source text: nBw3yhh5Ra
Further company coverage: MEDCL.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Medincell SA
See all newsBrief: Medincell Has Secured An Additional EUR 13.8 Million In Non-Dilutive Financing From Leading European Commercial Banks And Bpifrance
Teva gains after FDA approves monthly schizophrenia injection
Corrected: UPDATE 1-Teva wins FDA approval for monthly schizophrenia injection Weltruza
Teva wins FDA approval for monthly schizophrenia injection Weltruza
Brief: Medincell Announces Temporary Shares Trading Suspension On Euronext Paris